Immutep has concluded subject enrolment in the Phase II segment of the AIPAC-003 trial of eftilagimod alpha (efti) to treat ...

The BHF claims women are less likely than men to seek medical attention when experiencing a cardiac episode.

Arcus Biosciences has announced a clinical trial partnership with AstraZeneca to assess casdatifan plus volrustomig for renal ...

The company has received clearance from the US FDA to start an open-label Phase I trial for RespiRx nicotine inhaler in ...

SetPoint has already reported positive topline results for the trial in a separate study in rheumatoid arthritis.

On 26 September 2024, Bristol Myers Squibb (BMS) announced that the US Foof and Drug Administration approved Cobenfy ...

Muscle-sparing is particularly important in patients with heart failure as it is associated with higher mortality.

Johnson & Johnson has reported Phase III data where CARVYKTI improved overall survival in patients with multiple myeloma.

ProJenX and Unlearn partnered to implement genAI technology for a Phase I trial of prosetin for amyotrophic lateral sclerosis ...

The retrospective study presented at ESMO 2024 involved about 2,400 patients with stage 3 or 4 non-small cell lung cancer.

Longboard Pharmaceuticals has commenced the Phase III DEEp SEA Study of bexicaserin for treating seizures in Dravet syndrome ...

Moderna has dosed the first subject in the US in its Phase III Nova 301 clinical trial of its investigational norovirus vaccine, mRNA-1403.